Flagship Pioneering — 2021 Investments
8 investments dated 2021 · listed companies and verified rows first · show all
Generate:Biomedicines develops protein-based therapeutics using artificial intelligence and machine learning in a field it calls Generative Biology, combining computational protein design with biological engineering.
AI & Machine LearningBiotechDeep TechSomerville, US
Gevorg Grigoryan(Founder)inMichael Nally(Chief Executive Officer)inAvak Kahvejian(Founder)Geoffrey von Maltzahn(Founder)Molly Gibson(Founder)
Co-investorsAlumni VenturesARCH Venture PartnersMarch Capital PartnersNVIDIAAlaska Permanent Fund CorporationALTITUDE LIFE SCIENCE VENTURES+4 more
Alltrna develops engineered, chemically modified tRNA oligonucleotides as programmable medicines, using proprietary machine learning tools to design tRNA molecules with desired pharmacologic properties.
AI & Machine LearningBiotechDeep TechHealthtech
Lovisa Afzelius(Executive Chair & Founding CEO)inMichelle Werner(CEO)inJoanne Protano(President & Chief Financial Officer)inDave Hava(Chief Scientific Officer)inNerissa Kreher(Chief Medical Officer)inCaroline Köhrer(SVP, Discovery Platform)in
Cellarity develops medicines using artificial intelligence and single-cell biology to address disease at the cellular level rather than targeting individual disease markers.
AI & Machine LearningBiotechDeep TechMedical Devices
Avak Kahvejian Nick Plugis(Founder)
Co-investorsAhren Innovation CapitalManta Ray VenturesBlackRock
Ring Therapeutics develops vector-based targeted medicines using its Vectorology platform, which engineers conjugates derived from human commensal viruses to deliver diverse therapeutic payloads to specific tissues and cells.
BiotechDeep Tech
Chris McNulty(CEO)
Seventh Sense develops face-based biometric authentication solutions that verify identity without storing facial data, serving organizations and individuals needing secure access control, document signing, and identity verification.
AI & Machine LearningCybersecurityDeep TechDigital HealthSingapore, SG
Ashish KushwahaSam TsuiVarun Chatterji
Co-investors500 Global500 Startups VietnamFlagship VenturesNewpath Partners
Other
Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.
CIBOLarondeSeventh Sense Biosystems
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.

















